Day: March 25, 2025

Company AnnouncementRepurchase of up to 2.2 million shares with a maximum aggregate total value of DKK 4.0 billion Reduce the capital of Genmab and honor our commitments under the Restricted Stock Unit program Completion expected no later than July 10, 2025COPENHAGEN, Denmark; March 25, 2025 – Genmab A/S (Nasdaq: GMAB) announced today that it is initiating a share buy-back program, to reduce capital and to honor our commitments under the Restricted Stock Unit program. The share buy-back program will be undertaken on the terms set out below and in accordance with Regulation (EU) No. 596/2014 (‘MAR’) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the “Safe Harbour Regulation.” Time frame The share buy-back program will start on March 26, 2025, and is expected to end no later than July 10, 2025 (unless...

GUELPH, Ontario, March 25, 2025 (GLOBE NEWSWIRE) — Hammond Power Solutions Inc. (“HPS” or “Company”) (TSX: HPS.A) today announced the retirement of Grant Robinson from the board of directors of the Company, effective March 25, 2025. Grant was originally scheduled to retire at the upcoming shareholders meeting of the Company on May 8, 2025, but was recently diagnosed with a significant health issue that will require his immediate time and focus. The Board acknowledges and thanks Grant for an incredible 18 years of service to the Company.  His passion, business acumen and warm communication style helped build HPS into the great company it is today. Fred Jaques will immediately assume the lead director role and HPS expects to be adding two new independent directors to its board at its upcoming shareholder meeting on May 8, 2025. Caution...

Scottsdale, Ariz., March 25, 2025 (GLOBE NEWSWIRE) — CISO Global, Inc. (NASDAQ: CISO), an industry leader in AI-powered cybersecurity software, managed cybersecurity, and compliance, announced it has successfully paid off its highest-interest loans as part of its ongoing efforts to strengthen its balance sheet and improve operational efficiency. To further financial stability, CISO Global has also secured extensions on convertible notes totaling $7 million. These notes are held by long-standing partners with close relationships with the company, reflecting continued confidence in the long-term vision and stability of the business. “Clearing the company’s highest-interest debt removes a significant obstacle to our growth,” said Deb Smith, Chief Financial Officer of CISO Global. “With this burden lifted, we’ve improved our cash flow,...

BOSTON, March 25, 2025 (GLOBE NEWSWIRE) — Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that three abstracts relating to the company’s lead product candidate, ficerafusp alfa, will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2025, which will be held from April 25-30, 2025 in Chicago, IL. Ficerafusp alfa is a first-in-class bifunctional antibody that combines two clinically validated targets: an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-β) and is being evaluated across multiple solid tumor types. Details of the poster presentations are as follows: Title:...